The cross-linking theory in neurology is a concept which suggests that brain injury can be prevented or minimized by stimulating connections between damaged neurons. This theory proposes that increased synaptic connections between neurons and other neurons, or between damaged neurons and surrounding neurons, can help strengthen existing neural pathways and create new pathways, thus helping to repair injury and prevent further damage. It is based on the idea that increased neural connectivity in the brain, which is known as synaptogenesis, can promote CNS plasticity and recovery. The underlying principle of the theory is that the more neuromodulatory connections there are between neurons, the more synaptic changes occur, which allows the brain to respond to and adapt to damage from injury or disease. Researchers have used animal models, such as rats, to evaluate the effects of synaptogenesis on recovery and prevention of neurodegenerative diseases. In one study, the rats received a single dose of a drug which promotes synaptic connections and plasticity. They found that the drug not only enhanced recovery of damaged neural tissue, but it also prevented the onset of neurodegenerative diseases. The cross-linking theory is still largely theoretical due to a lack of research in humans. However, some clinical trials have shown promise in helping reduce the symptoms of stroke and other neurological diseases. For example, studies have shown that repetitive transcranial magnetic stimulation (rTMS) can be used to instigate plasticity and promote neuronal recovery. Although this theory is still in its early stages and it is yet to be proved in humans, it may prove to be an important tool in combating degenerative neurological diseases. It involves the rewiring of the brain itself, or using externally applied methods such as rTMS to increase connectivity, which may lead to possible treatments or therapies for those suffering from neurological disorders.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States